PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome

Stopped early · Not applicable

Conditions studied: Carpal Tunnel Syndrome, PRP

In brief

This study assesses the potential benefit of adjuvant platelet-rich plasma (PRP) with carpal tunnel release (CTR) for patients with severe carpal tunnel syndrome (CTS). CTR is a rather common procedure performed and seems to be quite effective for those with moderate CTS, but a number of patients with severe CTS do not have quite the same response post-CTR. The investigators will recruit patients who fall into the severe CTS category and compare CTR with and without adjuvant PRP to see if PRP can improve outcomes of this common surgery.

Key facts

Study ID
NCT04811287
Run by
Michael Fredericson, MD
People needed
15
Starts
2021-10-15
Expected to finish
2025-07-01
Last updated by the study team
2026-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.